Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine

BACKGROUND: Azvudine has been approved in China for the treatment of COVID-19 patients. Previous studies have suggested a correlation between high levels of lactate dehydrogenase (LDH) and the severity of COVID-19. However, the impact of LDH levels in COVID-19 patients receiving Azvudine treatment r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Manyun, Dian, Yating, Sun, Yuming, Chen, Wangqing, Zhu, Wu, Deng, Guangtong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619747/
https://www.ncbi.nlm.nih.gov/pubmed/37920449
http://dx.doi.org/10.3389/fcimb.2023.1237277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619747/
https://www.ncbi.nlm.nih.gov/pubmed/37920449
http://dx.doi.org/10.3389/fcimb.2023.1237277

Ejemplares similares